These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 812845)

  • 41. [Hyperuricemia as a risk factor of nephropathy in gout].
    Siniachenko OV; Diadyk AI; Nikolenko IuI; Vasilenko IV
    Ter Arkh; 1988; 60(1):97-101. PubMed ID: 3363519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis and treatment of chronic lead poisoning in CAPD patients.
    Kessler M; Durand PY; Hestin D; Gamberoni J; Chanliau J
    Adv Perit Dial; 1993; 9():143-6. PubMed ID: 8105909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical differentiation of lead gout from primary gout.
    Emmerson BT
    Arthritis Rheum; 1968 Oct; 11(5):623-34. PubMed ID: 5680985
    [No Abstract]   [Full Text] [Related]  

  • 44. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparative study of oral and intravenous tests using calcium-EDTA to measure lead deposits in the body].
    Sánchez Sánchez ML; Arroyo Vicente M; Elías Arcalís A; Rubio Pérez P
    Rev Clin Esp; 1983 May; 169(4):241-4. PubMed ID: 6414057
    [No Abstract]   [Full Text] [Related]  

  • 46. [Criteria in the diagnosis of lead poisoning. II. Lead levels in blood and urine corresponding to normal subjects and lead poisoning patients, in basal situations and after intravenous calcium EDTA administration].
    Sánchez Sánchez ML; Rubio Pérez P; Calvo Manuel E; Arroyo Vicente M; Millán Núñez-Cortés J; Espinos Pérez D
    Rev Clin Esp; 1979 May; 153(3):207-11. PubMed ID: 113852
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pathogenesis, diagnostics and therapy of gout].
    Zurek M
    Vnitr Lek; 2006; 52(7-8):736-41. PubMed ID: 16967617
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Primary skin gout. Observations and contribution on the clinical course of gout].
    Misgeld V
    Hautarzt; 1968 Jul; 19(7):299-304. PubMed ID: 5703349
    [No Abstract]   [Full Text] [Related]  

  • 49. Gout.
    Leong KH; Feng PH
    Singapore Med J; 1992 Aug; 33(4):393-4. PubMed ID: 1411672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CHRONIC LEAD NEPHROPATHY: THE DIAGNOSTIC USE OF CALCIUM EDTA AND THE ASSOCIATION WITH GOUT.
    EMMERSON BT
    Australas Ann Med; 1963 Nov; 12():310-24. PubMed ID: 14078907
    [No Abstract]   [Full Text] [Related]  

  • 51. A retrospect on 25 years of lead research.
    Goldberg A
    Health Bull (Edinb); 1983 Sep; 41(5):270-4. PubMed ID: 6643047
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experiences with oral and parenteral use of CaNa2 EDTA].
    Vasiljević S; Filipović DK; Andjelovski A
    Arh Hig Rada Toksikol; 1969; 20(4):679-86. PubMed ID: 4992050
    [No Abstract]   [Full Text] [Related]  

  • 53. [Mobilization of lead in patients with chronic poisoning by that metal. Oral penicillamine].
    González-Ramírez D; Zuñiga-Charles M; Narro-Juárez A
    Arch Invest Med (Mex); 1990; 21(3):279-83. PubMed ID: 2131778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Inhibition of endogenous synthesis of uric acid with allopurinol in patients with gout and urate diathesis].
    Holländer E; Schwarczmann P
    Munch Med Wochenschr; 1969 Aug; 111(32):1623-6. PubMed ID: 5394966
    [No Abstract]   [Full Text] [Related]  

  • 55. Gout, uric acid and renal disease.
    Emmerson BT
    Med J Aust; 1976 Mar; 1(12):403-5. PubMed ID: 1272125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anemia in chronic lead poisoning. Apropos of 2 cases].
    Cassagneau B; Laurent G; Capdeville J; Pris J
    Sem Hop; 1977 Mar 16-23; 53(11-12):679-85. PubMed ID: 194322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triglyceride concentrations in primary gout and gout of chronic lead nephropathy.
    Emmerson BT; Knowles BR
    Metabolism; 1971 Aug; 20(8):721-9. PubMed ID: 5568414
    [No Abstract]   [Full Text] [Related]  

  • 58. Gout and saturnism.
    Rapado A
    N Engl J Med; 1969 Oct; 281(15):851. PubMed ID: 5809524
    [No Abstract]   [Full Text] [Related]  

  • 59. Saturnine gout, redux: a review.
    Dalvi SR; Pillinger MH
    Am J Med; 2013 May; 126(5):450.e1-8. PubMed ID: 23510947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathogenesis of hyperuricemia in saturnine gout.
    Ball GV; Sorensen LB
    N Engl J Med; 1969 May; 280(22):1199-202. PubMed ID: 5767461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.